Amid the ongoing pandemic, the Diabetes Research Institute (DRI) Foundation continues to focus on raising funds for finding a cure for diabetes. We’re also tuned in to the needs of the diabetes community that we support. COVID-19 vaccinations are rolling out for many in the US, but where does that leave you or your loved ones with diabetes?
Many of you have been asking: Are the vaccines safe? We turned to DRI Director Dr. Camillo Ricordi, a leading expert in the field of diabetes research who has also been instrumental in treating diabetes patients that have COVID-19.
“The overall benefits for people with type 1 and type 2 far outweigh the risk of not receiving the vaccine,” stated Dr. Ricordi. “Diabetes is associated with increased severity of COVID-19, indicating an urgent and continued need to mitigate risk in this community. It is important that patients with diabetes receive the vaccine, and both types of diabetes should be prioritized.”
The Centers for Disease Control and Prevention (CDC) has recommended the following prioritization guidelines:
Phase 1a is in process, having begun in December 2020 immediately following the approval of the COVID-19 vaccines in the US. It includes frontline healthcare providers and residents of nursing homes, where COVID-19 cases and deaths have been dramatically highest.
Phase 1b is happening in some states already, includes people over the age of 74, and expands to more frontline workers, including first responders, food and agricultural workers, U.S. Postal Service workers, manufacturing workers, grocery store workers, public transit workers, teachers, and child care workers.
Phase 1c, depending on the state, is likely to begin in February or March 2021. This phase includes people over the age of 64, anyone else aged 16 or above with medical conditions that increase the risk for severe COVID-19, and all other essential workers, like those in transportation and logistics, water and wastewater, food service, construction, finance, information technology and communications, energy, legal, media, public safety, and public health workers.
What does this mean for people with
diabetes?
As written in the online health resource STAT, guidelines from the CDC released in December rank a person with type 2 diabetes as someone who “is at increased risk” of more severe illness from COVID-19. That means people with T2D will follow health care workers and people living in long-term care settings, getting their vaccines in Phase 1c of the rollout.
According to our sharing partners at Beyond Type 1, this means that for those with type 1 or any type of diabetes other than type 2, you are possibly (depending on your state) not included in the initial rollout and may need to wait to receive your vaccine with the general population, which is likely to be in April 2021 or later.
Yes, experts recommend people with diabetes get vaccinated against COVID-19.
These are the COVID-19 vaccines currently available in the United States.
- In mid-December 2020, Pfizer, a U.S. pharmaceutical corporation, and BioNTech, a German partner, made their first vaccine available to adults aged 16 and older. A second dose is needed 21 days after the initial shot. In May 2021, this vaccination was given the go-ahead for usage in kids 12 and olderTrusted Source. The Pfizer-BioNTech vaccine received complete approval from the Food and Drug Administration (FDA) in August 2021. Everyone over the age of 12 is entirely permitted to utilize it on an ongoing basis. For those over the age of 5, a third dose, or booster, is also offered.
- In late December 2020, American biotech company ModernaTrusted Source released their vaccine. Adults who are at least 18 years old may utilize it. With a 28-day interval between shots, this vaccination likewise calls for two doses. There is also a booster available.
- After receiving FDA approval, the vaccine was made available by the pharmaceutical company Johnson & Johnson (J&J)Trusted Source in late February 2021. In contrast to the Moderna and Pfizer-BioNTech vaccines, this one is unique. It simply needs one shot as opposed to two different doses. Additionally, unlike the others, it does not require storage at extremely low temperatures. For more information on the J&J vaccine, go here.
- U.S. pharma giant Pfizer BioNTech released the first vaccine, initially available in mid-December 2020, for those 16 and older. After the first shot, a second “booster” shot is required 21 days later.
- Biotech company Moderna released its vaccine in late December 2020 for adults 18 and older. This also requires two shots, with a 28-day break before the second dose.
Experts encourage the following people to get a booster shot:
- Everyone 5 years and older should get one booster after completing their primary vaccination series.
- People eligible for a second booster include adults 50 years and older, as well as kids 12 years and older who are considered
moderately or severely immunocompromised (e.g., receiving cancer treatment, organ transplant recipients).
Why should you get the vaccine?
One of the best methods to safeguard your health and fend off sickness is vaccination. Other measures, such as donning a mask that covers your mouth and nose and avoiding close contact with anyone you don't live with, also aid in halting the spread.
The most common side effects of COVID-19 vaccination are not specific to diabetes. They include:
- tenderness, swelling, and redness at the injection site
- fatigue
- headache
- chills
- fever
- nausea
- muscle aches
- After receiving their first vaccine dose (Moderna or Pfizer-BioNTech), approximately 10 to 15 percent reported elevated blood sugars for a day or two. After their second dose, 23 to 29 percent reported elevated sugars.
- After vaccination with the J&J vaccine, 42 percent had elevated sugars.
- Two percent reported lower blood sugars, and one person reported both higher and lower blood sugars (perhaps a combo of both, due to shifting glucose levels).
- After receiving the second vaccine, approximately 30 percent reported elevated blood sugars, and less than 1 percent reported lower blood sugars.
- No significant differences were reported based on the type of vaccine received, Moderna versus Pfizer-BioNTech.
0 Comments